• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌基因表达谱鉴定的侵袭性标志物。

Invasive markers identified by gene expression profiling in pancreatic cancer.

机构信息

Department of Surgery, Trinity College Dublin, The Adelaide and Meath Hospital Incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland.

出版信息

Pancreatology. 2012 Mar-Apr;12(2):130-40. doi: 10.1016/j.pan.2011.12.011. Epub 2011 Dec 31.

DOI:10.1016/j.pan.2011.12.011
PMID:22487523
Abstract

BACKGROUND

Molecular profiling has proven utility as a diagnostic and predictive tool in clinical oncology. However, a clinically relevant gene expression profile in pancreatic cancer remains elusive.

METHODS

Primary and metastatic pancreatic cancer cell lines (BxPC-3 and AsPC-1), were stimulated with phorbol-12-myristate 13-acetate (PMA), a known inducer of cell invasion. Affymetrix gene expression microarray analysis was performed, comparing gene expression to unstimulated controls. Differential expression was identified using ArrayAssist, and confirmed using quantitative real-time PCR. Bioinformatic analysis was performed using Pathway Studio and GOstat. The derived gene expression was further validated in fresh frozen pancreatic tumour samples. The ability of the derived 3 gene expression markersto differentiate between pancreatic adenocarcinoma (PDAC) and other neoplasms, and its association with clinicopathological variables was examined.

RESULTS

PMA-induced significant changes in cell line gene expression, from which distinctive 3 potential invasive markers were derived. Expression of these genes, uPA, MMP-1 and IL1-R1 was confirmed in human pancreatic tumours, and was found to differentiate PDAC from other pancreatic neoplasms. The expression of IL1-R1 in PDAC is a novel finding. We found that the expression of MMP-1 was associated with high-grade PDAC (p = 0.035, Wilcoxon rank sum).

CONCLUSION

We have identified three potential invasive markers, uPA, MMP-1 and IL1-R1, whose gene expression may differentiate PDAC from other pancreatic neoplasms, and potentially reflect a more invasive phenotype.

摘要

背景

分子谱已被证明在临床肿瘤学中是一种有诊断和预测价值的工具。然而,在胰腺癌中仍然难以找到与临床相关的基因表达谱。

方法

用佛波醇-12-肉豆蔻酸 13-醋酸盐(PMA)刺激原发性和转移性胰腺癌细胞系(BxPC-3 和 AsPC-1),PMA 是已知的细胞侵袭诱导剂。进行 Affymetrix 基因表达微阵列分析,将基因表达与未刺激的对照进行比较。使用 ArrayAssist 识别差异表达,并使用定量实时 PCR 进行确认。使用 Pathway Studio 和 GOstat 进行生物信息学分析。在新鲜冷冻的胰腺肿瘤样本中进一步验证所得的基因表达。检查所得的 3 个基因表达标志物区分胰腺腺癌(PDAC)和其他肿瘤的能力及其与临床病理变量的关系。

结果

PMA 诱导细胞系基因表达发生显著变化,从中衍生出 3 个潜在的侵袭性标志物。这些基因 uPA、MMP-1 和 IL1-R1 的表达在人类胰腺肿瘤中得到证实,并发现可区分 PDAC 与其他胰腺肿瘤。在 PDAC 中表达 IL1-R1 是一个新发现。我们发现 MMP-1 的表达与高级别 PDAC 相关(p = 0.035,Wilcoxon 秩和检验)。

结论

我们已经确定了三个潜在的侵袭性标志物,uPA、MMP-1 和 IL1-R1,其基因表达可能区分 PDAC 与其他胰腺肿瘤,并可能反映出更具侵袭性的表型。

相似文献

1
Invasive markers identified by gene expression profiling in pancreatic cancer.胰腺癌基因表达谱鉴定的侵袭性标志物。
Pancreatology. 2012 Mar-Apr;12(2):130-40. doi: 10.1016/j.pan.2011.12.011. Epub 2011 Dec 31.
2
Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.生长因子及尿激酶型纤溶酶原激活物系统在胰腺导管腺癌中的预后意义
Pancreas. 2008 Mar;36(2):160-7. doi: 10.1097/MPA.0b013e31815750f0.
3
Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.靶向miR-224和miR-486的CD40在胰腺导管腺癌进展中的作用
Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.
4
Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.胰腺癌多药耐药基因表达谱的基因芯片分析
Chin Med J (Engl). 2007 Oct 20;120(20):1743-52.
5
Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.使用实时定量逆转录聚合酶链反应检测胰腺腺癌中尿激酶型纤溶酶原激活剂的显著过表达
J Gastroenterol Hepatol. 2005 Feb;20(2):256-63. doi: 10.1111/j.1440-1746.2004.03531.x.
6
Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.尿激酶型纤溶酶原激活物/尿激酶型纤溶酶原激活物受体和 maspin 在口腔鳞状细胞癌中的表达:与浸润方式和临床病理因素的关系。
Oncol Rep. 2011 Dec;26(6):1555-60. doi: 10.3892/or.2011.1419. Epub 2011 Aug 10.
7
Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.胰腺癌侵袭转移机制分析:纤溶酶(原)级联蛋白在胰腺癌细胞侵袭中的作用
Int J Oncol. 2006 Feb;28(2):369-74.
8
Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.尿激酶型纤溶酶原激活物受体的抑制通过ERK/p38信号通路的调节抑制胰腺腺癌细胞的增殖和迁移。
Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1731-8. doi: 10.1016/j.biocel.2009.03.004. Epub 2009 Mar 21.
9
PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.甲状旁腺激素相关蛋白[67-86]调节乳腺癌细胞中应激蛋白的表达,诱导尿激酶型纤溶酶原激活剂和基质金属蛋白酶-1表达的改变。
J Cell Sci. 2003 Jun 15;116(Pt 12):2421-30. doi: 10.1242/jcs.00472. Epub 2003 Apr 30.
10
Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.癌细胞与基质成纤维细胞之间的相互作用是胰腺癌转移过程中激活uPAR-uPA-MMP-2级联反应所必需的。
Clin Cancer Res. 2007 Jun 1;13(11):3115-24. doi: 10.1158/1078-0432.CCR-06-2088.

引用本文的文献

1
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.尿激酶型纤溶酶原激活系统在胰腺癌中的作用:有前景的诊断和治疗靶点。
Biomolecules. 2022 Jan 18;12(2):152. doi: 10.3390/biom12020152.
2
High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.基质金属蛋白酶28高表达与胰腺腺癌预后不良相关。
Onco Targets Ther. 2021 Aug 10;14:4391-4406. doi: 10.2147/OTT.S309576. eCollection 2021.
3
Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?胰腺导管腺癌中的基质金属蛋白酶:疾病进展的关键驱动因素?
Biology (Basel). 2020 Apr 18;9(4):80. doi: 10.3390/biology9040080.
4
Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes.胰腺癌细胞对顺铂的获得性耐药是多因素的,耐药基因的参与取决于细胞背景。
Cancer Gene Ther. 2016 Dec;23(12):446-453. doi: 10.1038/cgt.2016.71. Epub 2016 Dec 2.
5
The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells.CaSm(LSm1)癌基因促进胰腺癌细胞的转化、化疗耐药性和转移。
Oncogenesis. 2016 Jan 11;5(1):e182. doi: 10.1038/oncsis.2015.45.
6
Self-Organizing Feature Maps Identify Proteins Critical to Learning in a Mouse Model of Down Syndrome.自组织特征映射识别唐氏综合征小鼠模型中对学习至关重要的蛋白质。
PLoS One. 2015 Jun 25;10(6):e0129126. doi: 10.1371/journal.pone.0129126. eCollection 2015.
7
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.微小RNA-221/222通过调控基质金属蛋白酶诱导胰腺癌进展。
Oncotarget. 2015 Jun 10;6(16):14153-64. doi: 10.18632/oncotarget.3686.
8
Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.冬凌草甲素介导的特征性变化对人胰腺癌(BxPC-3)细胞炎症信号通路的影响。
World J Gastroenterol. 2014 Oct 28;20(40):14895-903. doi: 10.3748/wjg.v20.i40.14895.
9
Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers.胰腺癌患者外周血的转录谱分析可识别诊断生物标志物。
Dig Dis Sci. 2014 Nov;59(11):2714-20. doi: 10.1007/s10620-014-3291-3. Epub 2014 Jul 29.
10
Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma.肿瘤细胞衍生的 MMP3 协调 Rac1b 和组织改变,促进胰腺腺癌的发生。
Mol Cancer Res. 2014 Oct;12(10):1430-9. doi: 10.1158/1541-7786.MCR-13-0557-T. Epub 2014 May 21.